期刊
PLANTA MEDICA
卷 79, 期 12, 页码 1038-1042出版社
GEORG THIEME VERLAG KG
DOI: 10.1055/s-0032-1328769
关键词
Alzheimers disease; amyloid peptide; -secretase; Geranium thunbergii; Geraniaceae
资金
- Basic Science Research Program through the National Research Foundation (NRF)
- Ministry of Education, Science, and Technology [2012-006723]
- Bio-industry Technology Development Program, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea [2011-311006-3]
- Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry & Fisheries (iPET), Republic of Korea [311006033SB010] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
- National Research Foundation of Korea [2012R1A1A2006723] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
Generation of amyloid beta peptide through the proteolytic process of amyloid precursor protein by beta-secretase and gamma-secretase is a main casual factor of Alzheimer's disease, since amyloid beta peptide is a major and crucial component of senile plaques in Alzheimer's disease brains. In the process of searching for beta-secretase inhibitors from natural resources, the EtOAc soluble fraction of Geranium thunbergii exhibited significant beta-secretase inhibitory activity. Two compounds, geraniin and corilagin, isolated from the most active EtOAc fraction of G. thunbergii, exhibited predominant inhibition against beta-secretase with IC50 values of 4.0 x 10(-6) M and 3.4 x 10(-5) M, respectively. Dixon plot of geraniin and corilagin demonstrated that the beta-secretase inhibition was noncompetitive with the substrate, thus clearly suggesting that these compounds might bind either to the beta-secretase subsites or to another regulatory domain with Ki values of 2.8 x 10(-6) M and 7.9 x 10(-5) M, respectively. Both compounds exhibited no significant inhibition against alpha-secretase and other serine proteases including trypsin and chymotrypsin, showing that they were relatively specific and selective inhibitors of beta-secretase. These novel findings suggest that geraniin and corilagin from G. thunbergii may be effective therapeutic agents for further drug development in Alzheimer's disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据